218
Views
6
CrossRef citations to date
0
Altmetric
Oncology: Original articles

Predictive value of a serum-based proteomic test in non-small-cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors: a meta-analysis

, , , , &
Pages 2033-2039 | Accepted 10 Jun 2014, Published online: 09 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ticiana A. Leal, Angela C. Argento, Krish Bhadra, D. Kyle Hogarth, Julia Grigorieva, Rachel M. Hartfield, Robert C. McDonald & Philip D. Bonomi. (2020) Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis. Current Medical Research and Opinion 36:9, pages 1497-1505.
Read now

Articles from other publishers (5)

Ru Wei. 2018. Advances in the Use of Liquid Chromatography Mass Spectrometry (LC-MS) - Instrumentation Developments and Applications. Advances in the Use of Liquid Chromatography Mass Spectrometry (LC-MS) - Instrumentation Developments and Applications 377 414 .
Olga Efimova, Brygida Berse, Daniel W. Denhalter, Scott L. DuVall, Kelly K. Filipski, Michael Icardi, Michael J. Kelley & Julie A. Lynch. (2017) Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration. BMC Medical Informatics and Decision Making 17:1.
Crossref
Ross A. Soo & Alex A. Adjei. (2017) Predicting Clinical Outcomes Using Proteomics in Non–Small Cell Lung Cancer—The Past, Present, and Future. Journal of Thoracic Oncology 12:4, pages 602-606.
Crossref
John E. Wiktorowicz & Allan R. Brasier. 2016. Modern Proteomics – Sample Preparation, Analysis and Practical Applications. Modern Proteomics – Sample Preparation, Analysis and Practical Applications 435 441 .
Wei Sun, Xun Yuan, Yijun Tian, Hua Wu, Hanxiao Xu, Guoqing Hu & Kongming Wu. (2015) Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer. Journal of Hematology & Oncology 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.